+ More Filters

Reset Filters

Title

Funding Organization

Funding Type

Eligible Country

Deadline

Other (Select all that apply)

Show Expired Programs

Show Verified Programs

Verified

Alpha-1-Antitrypsin Laurell's Training Award

Grifols

Identify and support innovative clinical and scientific research focused on gaining greater insight into the biologic roles of Alpha-1-Antitrypsin (AATD).

Offer young scientists and clinicians the opportunity to begin conducting research on AATD or further establish themselves in this area.
Establish new and long-lasting relationships with participating scientists and clinicians and strengthen the existing network between researchers and Grifols.

FUNDING

The award program consists of two annual grants of EUR 50,000 each. Funding is intended to support a 12 month project.

CRITERIA

Applications are evaluated based on four criteria:

Scientific merit
Innovation
Clinical / medical impact
Quality of research environment

CANDIDATES

The ALTA Award is available to early career clinicians and scientists who are new to the field, as well as those who are already studying AATD. Applicants should be under the age of 40 at the time of application. Investigators worldwide are encouraged to apply for this award.

APPLICATION PROCESS

Eligible applicants must submit a CV and a Letter of Intent outlining the aims of their research project. Application letters that fulfill the terms of entry will be assessed and judged by a Review Committee comprised of five experts from healthcare, research, and industry. Based on their review, the Committee will invite four candidates to submit a full research proposal. The Review Committee will evaluate the research proposals and select two award recipients.

AI Based Application Success Predictor

Grifols is industry-driven, so funding/collaboration success differs from academic grants:

🥇 1. Strong Alignment with Plasma-Based Therapies (Top Predictor)

Must relate to:
- Plasma proteins
- Immunoglobulins
- Blood products

✔ High success:

Studies using plasma-derived treatments

🥈 2. Clinical & Translational Relevance

Preference for:
- Human clinical studies
- Real-world patient outcomes

✔ Strong focus on therapeutic impact

🥉 3. Focus on Rare or Specialty Diseases

Priority areas:
- Immunodeficiency
- Hemophilia
- Neurological disorders

✔ Rare disease research is highly competitive

4. Feasibility & Regulatory Readiness

Industry emphasis on:
- Regulatory pathways
- Clinical trial feasibility

✔ Projects must be practical and approvable

5. Innovation in Therapeutics or Diagnostics

Competitive proposals include:
- New indications for plasma therapies
- Advanced diagnostic tools

6. Collaboration with Clinical Centers

Strong preference for:
- Hospitals
- Research institutions

✔ Industry–academic partnerships are key

7. Data-Driven & Evidence-Based Approach

Must include:
- Strong clinical data
- Measurable endpoints

8. Commercial & Scalability Potential

Important in industry context:
- Market relevance
- Scalability of therapy

🧪 Common Research/Collaboration Areas

Immunoglobulin therapy optimization
Hemophilia and bleeding disorders
Plasma protein therapies
Rare disease treatment
Blood diagnostics and safety
Neurological disease therapies

⚠️ Common Reasons for Rejection

No relevance to plasma or Grifols portfolio
Early-stage/basic research only
Lack of clinical applicability
Weak feasibility or regulatory pathway

🧠 Bottom Line (Key Predictors Ranked)

Alignment with plasma-based therapies
Clinical/translational relevance
Focus on rare or specialty diseases
Feasible and regulatory-ready design
Strong collaboration with clinical centers
Commercial/scalable potential

Specialties

Cell Biology

Others

Clinical Trials

Eligibility Requirements

Applications are evaluated based on four criteria:

Scientific merit
Innovation
Clinical / medical impact
Quality of research environment

Sponsor Details

Sponsor Institute/Organizations: Grifols

Sponsor Type: Corporate/Non-Profit

Address: Avinguda de la Generalitat, 152 Parque empresarial Can Sant Joan.

Legal & Affiliation Disclaimer

Affiliation Disclaimer: Trialect operates independently and is not affiliated with, endorsed by, or supported by any sponsors or organizations posting on the GrantsBoard platform. As an independent aggregator of publicly available funding opportunities, Trialect provides equal access to information for all users without endorsing any specific funding source, content, organization, or sponsor. Trialect assumes no responsibility for the content posted by sponsors or third parties.

Subscription Disclaimer: Upon logging into Trialect, you may choose to SUBSCRIBE to GrantsBoard for timely notifications of funding opportunities and to access exclusive benefits, such as priority alerts, reminders, personalized recommendations, and additional application support. However, users are advised to contact sponsors directly for any questions and are not required to subscribe to engage with funding opportunities.

Content Ownership and Copyright Disclaimer: Trialect respects the intellectual property rights of all organizations and individuals. All content posted on GrantsBoard is provided solely for informational purposes and remains the property of the original owners. Trialect does not claim ownership of, nor does it have any proprietary interest in, content provided by third-party sponsors. Users are encouraged to verify content and ownership directly with the posting sponsor.

Fair Use Disclaimer: The information and content available on GrantsBoard are compiled from publicly accessible sources in alignment with fair use principles under U.S. copyright law. Trialect serves as an aggregator of this content, offering it to users in good faith and with the understanding that it is available for public dissemination. Any organization or individual who believes their intellectual property rights have been violated is encouraged to contact us for prompt resolution.

Third-Party Posting Responsibility Disclaimer: Trialect is a neutral platform that allows third-party sponsors to post funding opportunities for informational purposes only. Sponsors are solely responsible for ensuring that their postings comply with copyright, trademark, and other intellectual property laws. Trialect assumes no liability for any copyright or intellectual property infringements in third-party content and will take appropriate action to address any substantiated claims.

Accuracy and Verification Disclaimer: Trialect makes no warranties regarding the accuracy, completeness, or reliability of the information provided by sponsors. Users are advised to verify the details of any funding opportunity directly with the sponsor before taking action. Trialect cannot be held liable for any discrepancies, omissions, or inaccuracies in third-party postings.

Notice and Takedown Policy: Trialect is committed to upholding copyright law and protecting the rights of intellectual property owners. If you believe that content on GrantsBoard infringes your copyright or intellectual property rights, please contact us with detailed information about the claim. Upon receipt of a valid notice, Trialect will promptly investigate and, where appropriate, remove or disable access to the infringing content.

View Funding Opportunity